VIALE-A: Venetoclax with or without in treatment-naïve patients with acute myeloid leukaemia

Bookmark and Share
Published: 13 Jun 2020
Views: 1818
Rating:
Save
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA

Dr Courtney DiNardo speaks to ecancer in an online interview for the virtual EHA 2020 meeting.

The VIALE-A trial is a a randomised, double-blind, placebo-controlled study of venetoclax with azacitidine vs azacitidine in treatment-naïve patients with acute myeloid leukaemia ineligible for intensive therapy.

Dr DiNardo provides a thorough background behind the study, before outlining the trial design and endpoints.

She then details the results including positive responses, and safety profile.

Read more about the study here